Wolfesberger J, Falkensammer C E, Madersbacher S
Abteilung für Urologie, Sozialmedizinisches Zentrum Süd, Kaiser-Franz-Josef-Spital mit Gottfried von Preyer'schem Kinderspital, Kundratstraße 3, 1100, Wien, Österreich.
Urologe A. 2017 Apr;56(4):456-464. doi: 10.1007/s00120-017-0339-y.
Bladder storage and voiding dysfunctions primarily affect patients aged 60 and upwards. Demographic changes and an age-related rise in prevalence underline the clinical relevance of these disorders. Besides behavior modification, the primary therapeutic approach is drug therapy. Therefore, a profound knowledge of the potential side effects is essential, particularly regarding the ever rising multidrug administration in the elderly. In this article, we provide a review concerning the potential adverse effects of the most popular therapeutic agents for bladder storage and voiding symptoms.
膀胱储尿和排尿功能障碍主要影响60岁及以上的患者。人口结构变化以及患病率随年龄增长而上升凸显了这些疾病的临床相关性。除了行为改变外,主要治疗方法是药物治疗。因此,深入了解潜在的副作用至关重要,尤其是考虑到老年人多药联用的情况日益增多。在本文中,我们对治疗膀胱储尿和排尿症状最常用药物的潜在不良反应进行了综述。